Variables associated with increased incidence of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes.
Sven H LoosenMünevver DemirAnselm KunsteinMarkus JördensNatalia QvarskhavaMark LueddeTom LueddeChristoph RoderburgKarel KostevPublished in: BMJ open diabetes research & care (2021)
Our data from a large population-based cohort of patients with T2D identified sociodemographic and therapeutic parameters associated with NAFLD incidence in patients with T2D which should be taken into account for novel therapeutic concepts.